These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 21269748)

  • 41. Anatomic and procedural predictors of paravalvular aortic regurgitation after implantation of the Medtronic CoreValve bioprosthesis.
    Sherif MA; Abdel-Wahab M; Stöcker B; Geist V; Richardt D; Tölg R; Richardt G
    J Am Coll Cardiol; 2010 Nov; 56(20):1623-9. PubMed ID: 21050971
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Syncope and aortic stenosis: significance of conduction abnormalities.
    Gann D; Fernandes H; Samet P
    Eur J Cardiol; 1979 May; 9(5):405-13. PubMed ID: 456398
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Incidence and predictors of atrioventricular conduction impairment after transcatheter aortic valve implantation.
    Roten L; Wenaweser P; Delacrétaz E; Hellige G; Stortecky S; Tanner H; Pilgrim T; Kadner A; Eberle B; Zwahlen M; Carrel T; Meier B; Windecker S
    Am J Cardiol; 2010 Nov; 106(10):1473-80. PubMed ID: 21059439
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Human minimally invasive off-pump valve-in-a-valve implantation.
    Walther T; Kempfert J; Borger MA; Fassl J; Falk V; Blumenstein J; Dehdashtian M; Schuler G; Mohr FW
    Ann Thorac Surg; 2008 Mar; 85(3):1072-3. PubMed ID: 18291201
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term evolution of pacemaker dependency after percutaneous aortic valve implantation with the corevalve prosthesis.
    Renilla A; Rubín JM; Rozado J; Moris C
    Int J Cardiol; 2015 Dec; 201():61-3. PubMed ID: 26292270
    [No Abstract]   [Full Text] [Related]  

  • 46. Intra-aortic phased-array imaging: new guiding tool for transcatheter aortic valve implantation.
    Bartel T; Müller L; Müller S
    Eur Heart J; 2009 Oct; 30(19):2368. PubMed ID: 19561026
    [No Abstract]   [Full Text] [Related]  

  • 47. Early conduction disorders following percutaneous aortic valve replacement.
    Calvi V; Puzzangara E; Pruiti GP; Conti S; Di Grazia A; Ussia GP; Capodanno D; Tamburino C
    Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S126-30. PubMed ID: 19250075
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transcatheter aortic valve implantation: time to expand?
    Walther T; Chu MW; Mohr FW
    Curr Opin Cardiol; 2008 Mar; 23(2):111-6. PubMed ID: 18303522
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Replacement of the quadricuspid aortic valve: strategy to avoid complete heart block.
    Pirundini PA; Balaguer JM; Lilly KJ; Gorsuch WB; Taft MB; Cohn LH; Rizzo RJ
    Ann Thorac Surg; 2006 Jun; 81(6):2306-8. PubMed ID: 16731182
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The utility of trans-catheter aortic valve replacement after commercialization: does the European experience provide a glimpse into the future use of this technology in the United States?
    Linke A; Walther T; Schuler G
    Catheter Cardiovasc Interv; 2010 Mar; 75(4):511-8. PubMed ID: 20088019
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Early structural valve deterioration of 18-mm Sorin Soprano aortic pericardial bioprosthesis.
    López Almodóvar LF; Lima P; Cañas A; Buendía J; Monguió E
    J Thorac Cardiovasc Surg; 2010 Apr; 139(4):e66-7. PubMed ID: 19660288
    [No Abstract]   [Full Text] [Related]  

  • 52. [Percutaneous implantation of aortic valve prosthesis in patients with symptomatic severe aortic stenosis rejected for surgical valve replacement].
    Moreno R; Calvo L; Filgueiras D; López T; Sánchez-Recalde A; Jiménez-Valero S; Galeote G; López-Sendón JL
    Rev Esp Cardiol; 2008 Nov; 61(11):1215-9. PubMed ID: 19000498
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Permanent pacemaker implantation after isolated aortic valve replacement: incidence, indications, and predictors.
    Dawkins S; Hobson AR; Kalra PR; Tang AT; Monro JL; Dawkins KD
    Ann Thorac Surg; 2008 Jan; 85(1):108-12. PubMed ID: 18154792
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Percutaneous aortic valve replacement with the CoreValve bioprosthesis.
    Zegdi R; Achouh P; Fabiani JN
    J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1407-8; author reply 1408. PubMed ID: 18544411
    [No Abstract]   [Full Text] [Related]  

  • 55. ECG of the month. Dyspnea and palpitations 16 years after tricuspid and aortic valve replacement. Atrial tachycardia (possibly slow atrial flutter) with 4:3 type I (Wenckebach) atrioventricular block, right bundle branch block, and left anterior fascicular block.
    Glancy DL; Jaligam VR; Saye VB; Wilklow FE
    J La State Med Soc; 2006; 158(1):5-6. PubMed ID: 16602476
    [No Abstract]   [Full Text] [Related]  

  • 56. Adherence to patient selection criteria in patients undergoing transcatheter aortic valve implantation with the 18F CoreValve ReValving System.
    Piazza N; Otten A; Schultz C; Onuma Y; Garcia-Garcia HM; Boersma E; de Jaegere P; Serruys PW
    Heart; 2010 Jan; 96(1):19-26. PubMed ID: 19744965
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hemodynamic results and changes in myocardial function after transcatheter aortic valve implantation.
    Gotzmann M; Lindstaedt M; Bojara W; Mügge A; Germing A
    Am Heart J; 2010 May; 159(5):926-32. PubMed ID: 20435207
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Percutaneous implantation of the self-expandable CoreValve for high risk patients with severe aortic valve stenosis: early Israeli experience.
    Danenberg H; Finkelstein A; Kornowski R; Segev A; Dvir D; Gilon D; Keren G; Sagie A; Feinberg M; Schwammenthal E; Banai S; Lotan C; Guetta V
    Isr Med Assoc J; 2010 Aug; 12(8):468-71. PubMed ID: 21337814
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The left axillary artery--a new approach for transcatheter aortic valve implantation.
    De Robertis F; Asgar A; Davies S; Delahunty N; Kelleher A; Trimlett R; Mullen M; Moat N
    Eur J Cardiothorac Surg; 2009 Nov; 36(5):807-12. PubMed ID: 19713120
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study.
    Grube E; Laborde JC; Gerckens U; Felderhoff T; Sauren B; Buellesfeld L; Mueller R; Menichelli M; Schmidt T; Zickmann B; Iversen S; Stone GW
    Circulation; 2006 Oct; 114(15):1616-24. PubMed ID: 17015786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.